Fairfax Financial Holdings’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Fairfax Financial Holdings’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-130,000	Closed	-$6.04M	–	63
2023 Q2	$6.04M	Buy	+130,000	New	+$4.49M	0.32%	22

Fairfax Financial Holdings's DICE Position: Q3 2023 in Review

Fairfax Financial Holdings sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 130,000 shares — an estimated $6.04M sold.

Fairfax Financial Holdings first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $6.04M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Fairfax Financial Holdings reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fairfax Financial Holdings sold 130,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.04M.
Fairfax Financial Holdings first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Fairfax Financial Holdings's DICE Therapeutics, Inc. Common Stock position peaked at $6.04M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Fairfax Financial Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.